[email protected]
Facebook
Twitter
LinkedIn
Instagram
YouTube
DRASA (Dr. Ameyo Stella Adadevoh) Health Trust
  • Home
  • COVID-19
    • Our COVID-19 Experience: The Last 6 Months
    • COVID-19 Education: Staying Safe
  • Who We Are
    • About Us
    • Dr. Ameyo Stella Adadevoh
    • Our People
      • Board of Advisors
      • Board of Trustees
      • Management Team
  • What We Do
    • Infection Prevention and Control (IPC)
      • Infection Prevention and Control (IPC) Training
      • COVID-19 Education: Staying Safe
    • Community Health & Hygiene
      • Youth Ambassadors
      • Community Health
    • Annual Reports
  • Get Involved
  • News & Blog
  • Contact Us
  • Donate

#IDFridays Week 5: Tuberculosis

Home #IDFridays #IDFridays Week 5: Tuberculosis

#IDFridays25/03/2016drasa_admin

Did you know Nigeria is one of the 22 countries with the highest rates of tuberculosis in the world?

#IDFridays Tuberculosis

Photo Credits: PBS, BBC

Name
Tuberculosis

Transmission

  • Tuberculosis (TB) is a potentially serious disease caused by the bacteria Mycobacterium tuberculosis
  • There are two types of TB infection:
    • ~1/3 of the world’s population is infected with the TB bacteria but not sick (called latent TB infection)
    • ~10% of those with latent TB infection will become ill (called active TB disease) and can then spread the disease to others
  • Person-to-person transmission occurs through the air when people with active TB disease cough, sneeze, or spit and the TB bacteria are inhaled by another person
  • TB mainly affects the lungs but can spread to other parts of the body

Geography
Worldwide

Incubation Period
No specified incubation period as some people live with latent TB infection without developing the full active TB disease

Signs and Symptoms

  • Cough (may include blood or mucus)
  • Fever
  • Night sweats
  • Weight loss
  • Chest pain
  • Weakness
  • Lack of appetite

Diagnosis

  • Skin test or a blood test
  • TB is difficult to diagnose in children

Treatment
Usually involves a 6-12 month course of 4 standard (called first-line) antimicrobial drugs which must be taken exactly as they are prescribed

Resistance

  • All over the world, there is an increasing prevalence of TB that is resistant to the drugs usually used to treat it
  • This resistance falls into two categories:
    • Multidrug-resistant TB (MDR-TB): Develops when TB bacteria do not respond to the standard first-line TB drugs. A primary cause of MDR-TB is misuse of drugs or mismanagement of treatment. MDR-TB must be treated with second-line TB drugs, which are more expensive and have more side-effects, and MDR-TB can take at least three times longer to cure (18-24 months). A person with MDR-TB can directly infect others with MDR-TB.
    • Extensively drug-resistant TB (XDR-TB): A very serious disease that develops when second-line drugs are misused or mismanaged and therefore also become ineffective. People with XDR-TB have fewer and more toxic treatment options and poor outcomes. A person with XDR-TB can directly infect others with XDR-TB.

Prognosis

  • Without treatment, 45% of people with active TB disease  will die
  • The risk of death is higher for people living with HIV, malnutrition, diabetes, or other conditions that suppress their immune systems
  • People living with HIV are 20 – 30 times more likely to develop TB and TB is a leading killer among this population (1 in 3 HIV deaths is due to TB)

Prevention: What Can You Do?

  • Avoid close contact or prolonged time with known TB patients in crowded, enclosed environments
  • If you know you have latent TB infection and you are at high risk of developing active TB disease, (if you are elderly, have HIV, malnutrition, diabetes, etc) speak with your healthcare provider about ways to prevent yourself from developing active TB disease

Sources:
http://www.cdc.gov/tb/topic/basics/default.htm
http://www.who.int/mediacentre/factsheets/fs104/en/
http://www.who.int/tb/areas-of-work/drug-resistant-tb/xdr-tb-faq/en/

Share on Facebook Share
Share on TwitterTweet
Share on Google Plus Share
Share on LinkedIn Share
Send email Mail

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Building a Healthier Future Through School-Based Health and Hygiene Clubs: Lessons from Stakeholders’ Visit
  • Accelerating Action Together: DRASA Celebrates World Hand Hygiene Day
  • Our DRASA Ambassadors Share Lessons Learned About Antimicrobial Resistance
  • Contagious Conversations on Preventing Infectious Diseases: Insights from the DRASA Radio Half-Hour
  • Investing in Health Workers is Crucial for Global Health: Here’s Why

Categories

  • #IDFridays
  • #ItStartsWithMe
  • Antimicrobial Resistance
  • Awards and Recognition
  • Community Outreach
  • DRASA Ambassadors
  • DRASA Radio Half Hour
  • Health Security
  • Humans of DRASA
  • Infection Prevention and Control
  • News
  • Outbreak Preparedness
  • Press Releases
  • Youth Engagement

Archives

  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • July 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • July 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • October 2015
  • September 2015
  • May 2015
  • April 2015

About Us

DRASA Health Trust is a nonprofit organization developing a network of health champions who take responsibility for their health and influence the health of those around them while also actively participating in solving public health challenges and preventing the spread of disease.

DRASA was established in memory of the late Dr. Ameyo Stella Adadevoh who identified and contained Nigeria's first Ebola patient, preventing a major epidemic, but lost her life in the process.

Recent Posts

  • Building a Healthier Future Through School-Based Health and Hygiene Clubs: Lessons from Stakeholders’ Visit 30/05/2023
  • Accelerating Action Together: DRASA Celebrates World Hand Hygiene Day 20/05/2023
  • Our DRASA Ambassadors Share Lessons Learned About Antimicrobial Resistance 20/04/2023
  • Contagious Conversations on Preventing Infectious Diseases: Insights from the DRASA Radio Half-Hour 15/04/2023
  • Investing in Health Workers is Crucial for Global Health: Here’s Why 04/04/2023

Contacts

17 Ibikunle Street, Yaba, Lagos, Nigeria
+234 (0) 803 613 1484
[email protected]
Email
Facebook
Twitter
LinkedIn
Instagram
YouTube
Website Design By RDM
© 2023 Dr. Ameyo Stella Adadevoh Health Trust - All Rights Reserved.